{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:34:18Z","timestamp":1793075658534,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.yebeh.2026.111323","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:29:35Z","timestamp":1790710175000},"page":"111323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Use of purified cannabidiol as add-on therapy in children with non-self-limited focal epilepsies of childhood: A multicenter study"],"prefix":"10.1016","volume":"185","author":[{"given":"Gabriela","family":"Reyes Valenzuela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Espeche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Fortini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Gamboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Adi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Semprino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Fasulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Galicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Cachia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Chac\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agustin","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Bautista","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6224-2596","authenticated-orcid":false,"given":"Viviana","family":"Venegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9010-7378","authenticated-orcid":false,"given":"Carolina","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1661-1542","authenticated-orcid":false,"given":"Paula","family":"Ivarola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Caraballo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.yebeh.2026.111323_b0005","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1111\/epi.17241","article-title":"International league against epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE task force on nosology and definitions","volume":"63","author":"Specchio","year":"2022","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.yebeh.2026.111323_b0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S2352-4642(22)00098-0","article-title":"Epilepsy surgery for children and adolescents: evidence-based but underused","volume":"6","author":"Cross","year":"2022","journal-title":"Lancet Child Adolesc Health"},{"issue":"4","key":"10.1016\/j.yebeh.2026.111323_b0015","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1080\/14737175.2024.2326606","article-title":"The latest advances in the pharmacological management of focal epilepsies in children: a narrative review","volume":"24","author":"Matricardi","year":"2024","journal-title":"Expert Rev Neurother"},{"issue":"21","key":"10.1016\/j.yebeh.2026.111323_b0020","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug- resistant seizures in the Dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.yebeh.2026.111323_b0025","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1714631","article-title":"GWPCARE3 study group. Effect of cannabidiol on drop seizures in the lennox-gastaut syndrome","volume":"378","author":"Devinsky","year":"2018","journal-title":"N Engl J Med"},{"issue":"10125","key":"10.1016\/j.yebeh.2026.111323_b0030","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"GWPCARE4 study group. Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.yebeh.2026.111323_b0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamaneurol.2020.4607","article-title":"GWPCARE6 study group. Add-on cannabidiol treatment for drug-resistant seizures in tuberous sclerosis complex: a placebo-controlled randomized clinical trial","volume":"78","author":"Thiele","year":"2021","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2026.111323_b0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2018.05.013","article-title":"Open-label use of highly purified CBD (Epidiolex\u00ae) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes","volume":"86","author":"Devinsky","year":"2018","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2026.111323_b0045","doi-asserted-by":"crossref","unstructured":"Cerulli Irelli E, Mazzeo A, Caraballo RH, Perulli M, Moloney PB, Pe\u00f1a-Ceballos J, et al.; GENE\u2010CBD study group; Orsini A, Coppola A. Expanding the therapeutic role of highly purified cannabidiol in monogenic epilepsies: a multicenter real-world study. Epilepsia. 2025;66(7):2253-67. doi: 10.1111\/epi.18378.","DOI":"10.1111\/epi.18378"},{"issue":"10","key":"10.1016\/j.yebeh.2026.111323_b0050","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1111\/epi.18496","article-title":"Long-term efficacy and safety of cannabidiol in patients with treatment-resistant focal epilepsies treated in the expanded access program","volume":"66","author":"Patel","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111323_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2023.109210","article-title":"Cannabidiol as an adjuvant treatment in adults with drug-resistant focal epilepsy","volume":"144","author":"Kochen","year":"2023","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2026.111323_b0060","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/epi4.12699","article-title":"Real-world data on cannabidiol treatment of various epilepsy subtypes: a retrospective, multicenter study","volume":"8","author":"K\u00fchne","year":"2023","journal-title":"Epilepsia Open"},{"issue":"1","key":"10.1016\/j.yebeh.2026.111323_b0065","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s42466-025-00408-w","article-title":"Use of cannabidiol for off-label treatment of patients with refractory focal, genetic generalised and other epilepsies","volume":"7","author":"Hollander","year":"2025","journal-title":"Neurol Res Pract"},{"issue":"6","key":"10.1016\/j.yebeh.2026.111323_b0070","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/epi.18338","article-title":"Updated classification of epileptic seizures: position paper of the international league against epilepsy","volume":"66","author":"Beniczky","year":"2025","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2026.111323_b0075","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/epi.17150","article-title":"Long-term cannabidiol treatment for seizures in patients with tuberous sclerosis complex: an open-label extension trial","volume":"63","author":"Thiele","year":"2022","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.yebeh.2026.111323_b0080","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s40263-021-00867-0","article-title":"Effect of cannabidiol on interictal epileptiform activity and sleep architecture in children with intractable epilepsy: a prospective open-label study","volume":"35","author":"Klotz","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.yebeh.2026.111323_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108558","article-title":"Electroencephalographic changes in purified pharmaceutical cannabidiol therapy","volume":"128","author":"Herlopian","year":"2022","journal-title":"Epilepsy Behav"},{"issue":"8","key":"10.1016\/j.yebeh.2026.111323_b0090","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/cpdd.665","article-title":"A phase 1, open-label, pharmacokinetic trial to investigate possible drug-drug interactions between clobazam, stiripentol, or valproate and cannabidiol in healthy subjects","volume":"8","author":"Morrison","year":"2019","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.yebeh.2026.111323_b0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yebeh.2019.03.042","article-title":"Higher cannabidiol plasma levels are associated with better seizure response following treatment with a pharmaceutical grade cannabidiol","volume":"95","author":"Szaflarski","year":"2019","journal-title":"Epilepsy Behav"},{"issue":"4","key":"10.1016\/j.yebeh.2026.111323_b0100","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/epi.18255","article-title":"Population pharmacokinetics of cannabidiol and the impact of food and formulation on systemic exposure in children with drug-resistant developmental and epileptic encephalopathies","volume":"66","author":"Brstilo","year":"2025","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2026.111323_b0105","doi-asserted-by":"crossref","unstructured":"Miller I, Scheffer IE, Gunning B, Sanchez-Carpintero R, Gil-Nagel A, Perry MS, et al.; GWPCARE2 study group. Dose-ranging effect of adjunctive oral cannabidiol vs placebo on convulsive seizure frequency in dravet syndrome: a randomized clinical trial. JAMA Neurol 2020;77(5):613-621. doi: 10.1001\/jamaneurol.2020.0073. Erratum in: JAMA Neurol. 2020 May 1;77(5):655. doi: 10.1001\/jamaneurol.2020.0749.","DOI":"10.1001\/jamaneurol.2020.0073"},{"key":"10.1016\/j.yebeh.2026.111323_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2025.110590","article-title":"A multicenter study on the use of purified cannabidiol for children with treatment-resistant developmental and epileptic encephalopathies","volume":"171","author":"Reyes Valenzuela","year":"2025","journal-title":"Epilepsy Behav"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026004440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026004440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T04:30:01Z","timestamp":1793075401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026004440"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":22,"alternative-id":["S1525505026004440"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111323","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of purified cannabidiol as add-on therapy in children with non-self-limited focal epilepsies of childhood: A multicenter study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.111323","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111323"}}